Anzeige
Mehr »
Login
Montag, 17.02.2020 Börsentäglich über 12.000 News von 619 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Xconomy

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SaAgile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch
FrBio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution's IPO & More
FrEisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
DoRevolution Medicines IPO Reels In $238M to Take On RAS in Cancer
MiLigand's Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential
MiCRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
DiTwo Big Pharma Alliances End in Nixed Deals. Here's What Happened.
DiFDA Clinical Hold Stops LogicBio's Gene Editing Study Before It Starts
10.02.Wave Life Sciences' Stumble in Duchenne Leads to 22% Staff Layoff
10.02.Biohaven Drug Fails Anxiety Study, Data in OCD and More Still to Come
10.02.Eli Lilly, Roche Drugs Fail to Move Needle in Genetically-Driven Alzheimer's
07.02.Bio Roundup: POTUS on Prices, a16z's Fund, Aimmune's Approval & More
07.02.Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer
06.02.Scripps Research's Calibr to Test "Switchable" CAR-T in Clinical Trial
06.02.Early Bird Sale Ending for San Diego's Xcelerating Life Sciences Conference
06.02.Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered
06.02.Coda Bio Acquires Drug Candidates to Pair With Engineered Receptors
05.02.Aimmune Gets $200M From Nestlé; Licenses Food Allergy Drug Candidate
05.02.Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff
05.02.Titan Medical's Cash Crunch Stalls Plans to Get Surgical Robot to FDA
05.02.Vertily, Santen See Opthalmology Opportunity Via New Joint Venture
04.02.$750M Fund Looks to Software Sector to Drive Future of Biotech
04.02.Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup
04.02.Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic
03.02.Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals